Healthcare Professionals Event Listing

1 - 6 of 6

The CAR-T Revolution 3 Years After FDA Approval

Torie CART

Three years after FDA approval of the first CAR-T therapy, Dr. Grupp will review outcomes data and provide an update on advancements and new trials in the field of cancer immunotherapy for patients with relapsed acute lymphoblastic leukemia (ALL).

Dec 15, 2020 from 5 p.m. - 6:30 p.m. (ET)

Curative and Emerging Therapies for Sickle Cell Disease

Caylin smiling

In this lecture, we will provide an overview for general practitioners and hematologists in which we review limitations of current therapies for sickle cell disease, pivotal data leading to the emergence of novel therapies, and approaches to deciding which therapies are optimal for individual patients.

Jan 15, 2021 from 7:30 a.m. - 8:30 a.m. (ET)

Cancer Predisposition and Surveillance in Children and Adolescents


During this webinar, we will present the general approach to patients with a possible cancer predisposition syndrome, review a few of the more common cancer surveillance syndromes, and discuss future directions in the field of pediatric cancer predisposition.

Jan 19, 2021 from 5:30 p.m. - 6:30 p.m. (ET)